ODDO BHF Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04M Hold
10,151
0.23% 107
2026
Q1
$4.53M Sell
10,151
-36,482
-78% -$17M 0.18% 121
2025
Q4
$21.1M Buy
46,633
+13,355
+40% +$5.76M 0.79% 31
2025
Q3
$13M Buy
33,278
+20,890
+169% +$8.73M 0.5% 53
2025
Q2
$5.52M Sell
12,388
-4,309
-26% -$1.99M 0.21% 126
2025
Q1
$8.1M Sell
16,697
-1,076
-6% -$501K 0.33% 85
2024
Q4
$7.16M Buy
17,773
+760
+4% +$352K 0.36% 82
2024
Q3
$7.91M Buy
+17,013
New +$8.17M 0.39% 73

Other funds holding VRTX

ODDO BHF Asset Management's VRTX Position: Q2 2026 in Review

ODDO BHF Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 10,151 shares worth $5.04M. The position accounts for 0.23% of the portfolio, ranked #107.

ODDO BHF Asset Management first reported a position in VRTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $21.1M in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • ODDO BHF Asset Management held 10,151 shares of Vertex Pharmaceuticals worth $5.04M as of Q2 2026.
  • ODDO BHF Asset Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.23% of ODDO BHF Asset Management's portfolio in Q2 2026, its #107 holding.
  • ODDO BHF Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • ODDO BHF Asset Management's Vertex Pharmaceuticals position peaked at $21.1M in Q4 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on ODDO BHF Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.